Insider Transactions in Q4 2021 at Karuna Therapeutics, Inc. (KRTX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2021
|
Stephen K. Brannan Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
15,000
-66.67%
|
-
|
|
Dec 21
2021
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,970
+11.98%
|
$62,730
$9.2 P/Share
|
|
Dec 01
2021
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,728
-27.87%
|
$981,456
$127.57 P/Share
|
|
Dec 01
2021
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,228
+16.45%
|
$61,368
$6.36 P/Share
|
|
Dec 01
2021
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$317,500
$127.73 P/Share
|
|
Dec 01
2021
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|
|
Nov 15
2021
|
Laurie J Olson |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$138,000
$138.24 P/Share
|
|
Nov 15
2021
|
Laurie J Olson |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$84,000
$84.86 P/Share
|
|
Nov 08
2021
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,500
-42.86%
|
$2,052,000
$152.32 P/Share
|
|
Nov 08
2021
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,500
+30.0%
|
$121,500
$9.2 P/Share
|
|
Nov 02
2021
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
26,500
+32.79%
|
$53,000
$2.92 P/Share
|
|
Nov 01
2021
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$340,000
$136.67 P/Share
|
|
Nov 01
2021
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|
|
Nov 01
2021
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,728
-15.47%
|
$1,051,008
$136.67 P/Share
|
|
Nov 01
2021
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,228
+12.12%
|
$61,368
$6.06 P/Share
|
|
Nov 01
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
2,827
-0.89%
|
$398,607
$141.29 P/Share
|
|
Oct 04
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
3,029
-9.82%
|
$378,625
$125.17 P/Share
|
|
Oct 01
2021
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
13,471
-5.53%
|
$1,643,462
$122.08 P/Share
|
|
Oct 01
2021
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$300,000
$120.72 P/Share
|
|
Oct 01
2021
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|